Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Los Angeles, California 90048


At Cedars-Sinai Medical Center, we have developed a novel curriculum for a 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™ (Haze). Each series meets once a week for 2 hours for 6 weeks. The leading neuropsychologist covers material such as guided relaxation, behavioral strategies for automatic/negative thoughts, compensatory strategies for attention and memory, executive functioning, pacing, and balance. Each Haze series will be electronically delivered in a live format to our satellite site, The University of Kansas.


Inclusion Criteria: - Completed treatment for stage 1-3 breast cancer at least two months but not more than 24 months prior to enrollment. - Having received chemotherapy with or without radiation therapy - Female, Age ≥18 years. - FACT-Cog score less than 59 on the Perceived Cognitive Impairment subscale - Eligible after 2 months of completing all their active cancer treatment with the exception of long-term hormonal treatments or trastuzumab. - Subjective complaint of cognitive concerns at time of enrollment - Must be able to understand and communicate proficiently in English - Ability to understand and the willingness to sign a written informed consent. - Agree to complete study surveys Exclusion Criteria: - Patients who have significant personality disorders or unstable psychiatric disorders (including active major depression, substance abuse, psychosis or bipolar disorder) as assessed by the interviewing clinician - Patients with known brain metastases, history of brain metastases or radiation to the brain. - Patients with a history of stroke or other pre-existing neurological condition that may contribute to cognitive dysfunction. - Non-English speakers - Receiving treatment for another malignancy other than breast cancer - Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, chronic anemia, uncontrolled hypothyroidism, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.



Primary Contact:

Principal Investigator
Jamie Myers, PhD, RN AOCNSP
University of Kansas

Backup Contact:


Location Contact:

Los Angeles, California 90048
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.